(MPAA) Motorcar Parts of America - Overview
Stock: Alternator, Starter, Brake Caliper, Turbocharger, Hub Assembly
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 62.1% |
| Relative Tail Risk | -9.26% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.38 |
| Alpha | 92.32 |
| Character TTM | |
|---|---|
| Beta | 0.803 |
| Beta Downside | 1.014 |
| Drawdowns 3y | |
|---|---|
| Max DD | 67.93% |
| CAGR/Max DD | -0.03 |
Description: MPAA Motorcar Parts of America January 01, 2026
Motorcar Parts of America (NASDAQ: MPAA) manufactures, remanufactures and distributes replacement parts for heavy-duty trucks, industrial, marine and agricultural equipment across three segments: Hard Parts, Test Solutions & Diagnostic Equipment, and Heavy Duty.
The Hard Parts line includes light-duty rotating electrical components (alternators, starters), wheel hub assemblies, bearings and a full brake-system portfolio (calipers, boosters, rotors, pads, master cylinders), as well as turbochargers. The Test Solutions segment supplies bench-top testers for alternators and starters, EV pre- and post-production equipment, and software emulators for power-system electrification. The Heavy-Duty segment focuses on non-discretionary aftermarket hard parts for trucks, industrial, marine and ag applications, sold to North-American retail chains, warehouse distributors and OEM aftermarket programs.
Key industry drivers include the aging U.S. heavy-truck fleet-average age ≈ 8 years, prompting higher parts demand-and the accelerating shift toward electrified commercial vehicles, which is expanding the market for diagnostic and testing solutions. MPAA’s FY 2024 revenue grew ~ 12 % YoY to $1.1 bn, with a gross margin of 28 % and inventory turnover of 5.3×, reflecting both pricing power and efficient supply-chain management.
Investors tracking aftermarket exposure should note that MPAA’s private-label brands (Quality-Built, Pure Energy, D&V Electronics, etc.) capture roughly 65 % of sales, providing pricing flexibility in a sector where OEM-direct competition is limited.
For a deeper quantitative view, you may want to explore MPAA’s metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 2.46m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 2.56 > 1.0 |
| NWC/Revenue: 21.79% < 20% (prev 20.86%; Δ 0.93% < -1%) |
| CFO/TA 0.08 > 3% & CFO 75.4m > Net Income 2.46m |
| Net Debt (175.2m) to EBITDA (73.9m): 2.37 < 3 |
| Current Ratio: 1.46 > 1.5 & < 3 |
| Outstanding Shares: last quarter (19.4m) vs 12m ago -1.99% < -2% |
| Gross Margin: 20.28% > 18% (prev 0.18%; Δ 2010 % > 0.5%) |
| Asset Turnover: 79.86% > 50% (prev 74.97%; Δ 4.89% > 0%) |
| Interest Coverage Ratio: 1.22 > 6 (EBITDA TTM 73.9m / Interest Expense TTM 52.5m) |
Altman Z'' 1.68
| A: 0.17 (Total Current Assets 546.7m - Total Current Liabilities 374.8m) / Total Assets 990.0m |
| B: 0.02 (Retained Earnings 20.9m / Total Assets 990.0m) |
| C: 0.06 (EBIT TTM 64.0m / Avg Total Assets 988.1m) |
| D: 0.04 (Book Value of Equity 26.4m / Total Liabilities 731.4m) |
| Altman-Z'' Score: 1.68 = BB |
Beneish M -3.20
| DSRI: 0.91 (Receivables 134.3m/137.7m, Revenue 789.1m/739.4m) |
| GMI: 0.90 (GM 20.28% / 18.30%) |
| AQI: 1.03 (AQ_t 0.35 / AQ_t-1 0.34) |
| SGI: 1.07 (Revenue 789.1m / 739.4m) |
| TATA: -0.07 (NI 2.46m - CFO 75.4m) / TA 990.0m) |
| Beneish M-Score: -3.20 (Cap -4..+1) = AA |
What is the price of MPAA shares?
Over the past week, the price has changed by -1.77%, over one month by +1.91%, over three months by -27.86% and over the past year by +112.46%.
Is MPAA a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MPAA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 20 | 56.4% |
| Analysts Target Price | 20 | 56.4% |
| ValueRay Target Price | 13.6 | 6.3% |
MPAA Fundamental Data Overview February 02, 2026
P/E Forward = 9.2851
P/S = 0.3081
P/B = 0.9411
P/EG = 0.55
Revenue TTM = 789.1m USD
EBIT TTM = 64.0m USD
EBITDA TTM = 73.9m USD
Long Term Debt = 43.4m USD (from longTermDebt, last quarter)
Short Term Debt = 83.4m USD (from shortTermDebt, last quarter)
Debt = 191.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 175.2m USD (from netDebt column, last quarter)
Enterprise Value = 416.3m USD (243.1m + Debt 191.0m - CCE 17.7m)
Interest Coverage Ratio = 1.22 (Ebit TTM 64.0m / Interest Expense TTM 52.5m)
EV/FCF = 5.95x (Enterprise Value 416.3m / FCF TTM 70.0m)
FCF Yield = 16.81% (FCF TTM 70.0m / Enterprise Value 416.3m)
FCF Margin = 8.87% (FCF TTM 70.0m / Revenue TTM 789.1m)
Net Margin = 0.31% (Net Income TTM 2.46m / Revenue TTM 789.1m)
Gross Margin = 20.28% ((Revenue TTM 789.1m - Cost of Revenue TTM 629.1m) / Revenue TTM)
Gross Margin QoQ = 19.29% (prev 18.01%)
Tobins Q-Ratio = 0.42 (Enterprise Value 416.3m / Total Assets 990.0m)
Interest Expense / Debt = 6.65% (Interest Expense 12.7m / Debt 191.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = 50.6m (EBIT 64.0m * (1 - 21.00%))
Current Ratio = 1.46 (Total Current Assets 546.7m / Total Current Liabilities 374.8m)
Debt / Equity = 0.74 (Debt 191.0m / totalStockholderEquity, last quarter 258.5m)
Debt / EBITDA = 2.37 (Net Debt 175.2m / EBITDA 73.9m)
Debt / FCF = 2.50 (Net Debt 175.2m / FCF TTM 70.0m)
Total Stockholder Equity = 259.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.25% (Net Income 2.46m / Total Assets 990.0m)
RoE = 0.95% (Net Income TTM 2.46m / Total Stockholder Equity 259.8m)
RoCE = 21.10% (EBIT 64.0m / Capital Employed (Equity 259.8m + L.T.Debt 43.4m))
RoIC = 13.17% (NOPAT 50.6m / Invested Capital 383.9m)
WACC = 7.28% (E(243.1m)/V(434.1m) * Re(8.87%) + D(191.0m)/V(434.1m) * Rd(6.65%) * (1-Tc(0.21)))
Discount Rate = 8.87% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.68%
[DCF Debug] Terminal Value 73.64% ; FCFF base≈59.8m ; Y1≈39.2m ; Y5≈17.9m
Fair Price DCF = 11.60 (EV 402.1m - Net Debt 175.2m = Equity 226.9m / Shares 19.6m; r=7.28% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -34.24 | EPS CAGR: -13.56% | SUE: -2.53 | # QB: 0
Revenue Correlation: 72.09 | Revenue CAGR: 8.73% | SUE: 0.18 | # QB: 0
EPS next Year (2027-03-31): EPS=1.75 | Chg30d=-0.615 | Revisions Net=+0 | Growth EPS=+90.8% | Growth Revenue=+5.8%